HIGHLIGHTS
- who: Ivan Guryanov and collaborators from the Institute of Chemistry, StPetersburg State University, Universitetsky pr26, Peterhof, St. Petersburg, Russia have published the paper: Peptide Inhibitors of Vascular Endothelial Growth Factor A: Current Situation and Perspectives, in the Journal: Pharmaceutics 2021, x of /2021/
- what: The enhancement of the efficiency, selectivity, and targeting of the pharmaceuticals to the desired biomolecules and cells is one of the main objectives of modern drug design. The research was carried out to determine minimal structural elements of heparin, which are necessary for VEGFA binding. Later, the analysis of peptide libraries . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.